In plain language
This narrative review reports that robotic coronary intervention may lower radiation exposure and orthopedic strain for interventional cardiologists, with good short-term safety, but long-term randomized evidence is still needed and technical limitations remain.
At a glance
- Type of study
- Narrative review
- Who was studied
- Interventional cardiologists
- Summary based on
- the abstract
What it found
Robotic percutaneous coronary intervention (PCI) is described as reducing radiation exposure and orthopedic injuries for interventional cardiologists.
Large cohort studies support short-term safety and high technical success of robotic PCI, but randomized long-term data are lacking.
Current challenges include delays, conversion to manual PCI for unstable patients, and incompatibility with thrombus aspiration catheters and heavily calcified lesions.
Tele-stenting for complex coronary lesions is identified as a promising future application.
Limits to keep in mind
Narrative review summarised from the abstract only, with no systematic search or quantitative data on staff dose reduction.
Related research summaries
- Radiation exposure in interventional cardiology: a narrative review of health effects and novel approaches to ensure radiation safety (2025, Narrative review)
- Radiation Exposure, Training, and Safety in Cardiology (2024, Narrative review)
- Robotically Assisted Percutaneous Coronary Intervention: Benefits to the Patient and to the Cardiologist (2015, Editorial or commentary)
- Practical guidance to reduce radiation exposure in electrophysiology applying ultra low-dose protocols: a European Heart Rhythm Association review (2023, Narrative review)
- Remote Magnetic Catheter Navigation Versus Conventional Ablation In Atrial Fibrillation Ablation: Fluoroscopy Reduction (2016, Retrospective cohort study)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.